Scarica l'app Stockscreener
11.41
6.24%
-0.76
Benitec Biopharma Inc Azioni (BNTC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | 0.007 | 0.054 |
Operating Expenses
|
40.22%
4.141
|
6.927 | 5.874 | 4.557 | 4.395 |
| Operating Income/Loss |
40.22%
-4.141
|
-6.927 | -5.874 | -4.55 | -4.341 |
| Nonoperating Income/Loss |
206.98%
-0.138
|
0.129 | -0.08 | -0.111 | -0.056 |
| Income/Loss From Continuing Operations Before Tax |
37.06%
-4.279
|
-6.798 | -5.954 | 0.007 | 0.054 |
| Income/Loss From Continuing Operations After Tax |
37.06%
-4.279
|
-6.798 | -5.954 | -4.661 | -4.397 |
|
Net Income/Loss
|
37.06%
-4.279
|
-6.798 | -5.954 | -4.661 | -4.397 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.55%
2.6163
|
2.5763 | 2.1571 | -20.70 | 27.98 |
| Diluted Average Shares |
1.55%
2.6163
|
2.5763 | 2.1571 | -20.70 | 27.98 |
| Basic Earnings Per Share |
37.88%
-1.64
|
-2.64 | -2.76 | -13.45 | -0.16 |
| Diluted Earnings Per Share |
37.88%
-1.64
|
-2.64 | -2.76 | -13.45 | -0.16 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):